Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heilmann

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Journal of the American Veterinary Medical Association|December 18, 2014
Evaluation of serum biochemical marker concentrations and survival time in dogs with protein-losing enteropathyMirjam Equilino, Vincent Théodoloz, Daniela Gorgas, et al.
Journal of Veterinary Internal Medicine|November 20, 2016
Hyperhomocysteinemia in Greyhounds and its Association with Hypofolatemia and Other Clinicopathologic VariablesR M Heilmann, N Grützner, M C Iazbik, et al.
Cancer Research Communications|April 3, 2025
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid TumorsDazhi Liu, Justin Jee, Alexander Drilon, et al.
Journal of Veterinary Internal Medicine|April 7, 2018
Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel diseaseCristiane C Otoni, Romy M Heilmann, Mercedes García-Sancho, et al.
BMC Veterinary Research|November 10, 2023
Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogsJana Weinekötter, Corinne Gurtner, Martina Protschka, et al.
The Oncologist|September 8, 2023
Insights of Clinical Significance From 109 695 Solid Tumor Tissue-Based Comprehensive Genomic ProfilesAndreas M Heilmann, Jonathan W Riess, Margaret McLaughlin-Drubin, et al.
Journal of Veterinary Internal Medicine|February 26, 2026
ACVIM-endorsed statement: consensus statement and systematic review on guidelines for the diagnosis and treatment of chronic inflammatory enteropathy in dogsRomy M Heilmann, Albert E Jergens, Aarti Kathrani, et al.
Veterinary Journal (London, England : 1997)|December 4, 2015
Serum and fecal canine α1-proteinase inhibitor concentrations reflect the severity of intestinal crypt abscesses and/or lacteal dilation in dogsRomy M Heilmann, Nolie K Parnell, Niels Grützner, et al.
Genes & Development|January 17, 2013
Loss of RBF1 changes glutamine catabolismBrandon N Nicolay, Paulo A Gameiro, Katrin Tschöp, et al.
Case Reports in Oncology|May 14, 2020
Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating MutationJamie A Kmak, Nikita Agarwal, Yuting He, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Journal of the American Veterinary Medical Association|December 18, 2014
Evaluation of serum biochemical marker concentrations and survival time in dogs with protein-losing enteropathyMirjam Equilino, Vincent Théodoloz, Daniela Gorgas, et al.
Journal of Veterinary Internal Medicine|November 20, 2016
Hyperhomocysteinemia in Greyhounds and its Association with Hypofolatemia and Other Clinicopathologic VariablesR M Heilmann, N Grützner, M C Iazbik, et al.
Cancer Research Communications|April 3, 2025
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid TumorsDazhi Liu, Justin Jee, Alexander Drilon, et al.
Journal of Veterinary Internal Medicine|April 7, 2018
Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel diseaseCristiane C Otoni, Romy M Heilmann, Mercedes García-Sancho, et al.
BMC Veterinary Research|November 10, 2023
Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogsJana Weinekötter, Corinne Gurtner, Martina Protschka, et al.
The Oncologist|September 8, 2023
Insights of Clinical Significance From 109 695 Solid Tumor Tissue-Based Comprehensive Genomic ProfilesAndreas M Heilmann, Jonathan W Riess, Margaret McLaughlin-Drubin, et al.
Journal of Veterinary Internal Medicine|February 26, 2026
ACVIM-endorsed statement: consensus statement and systematic review on guidelines for the diagnosis and treatment of chronic inflammatory enteropathy in dogsRomy M Heilmann, Albert E Jergens, Aarti Kathrani, et al.
Veterinary Journal (London, England : 1997)|December 4, 2015
Serum and fecal canine α1-proteinase inhibitor concentrations reflect the severity of intestinal crypt abscesses and/or lacteal dilation in dogsRomy M Heilmann, Nolie K Parnell, Niels Grützner, et al.
Genes & Development|January 17, 2013
Loss of RBF1 changes glutamine catabolismBrandon N Nicolay, Paulo A Gameiro, Katrin Tschöp, et al.
Case Reports in Oncology|May 14, 2020
Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating MutationJamie A Kmak, Nikita Agarwal, Yuting He, et al.
Pageof 15